EP Patent

EP2415460A1 — Orale Darreichungsform von Pregabalin

Assigned to Ratiopharm GmbH · Expires 2012-02-08 · 14y expired

What this patent protects

Die Erfindung betrifft orale Darreichungsformen zur modifizierten Freisetzung von Pregabalin sowie Verfahren zu deren Herstellung.

USPTO Abstract

Die Erfindung betrifft orale Darreichungsformen zur modifizierten Freisetzung von Pregabalin sowie Verfahren zu deren Herstellung.

Drugs covered by this patent

Patent Metadata

Patent number
EP2415460A1
Jurisdiction
EP
Classification
—
Expires
2012-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.